ArticleScientific reports2025
Predicting outcomes in patients with sepsis-associated encephalopathy using prefrontal functional connectivity analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Diagnostic models for sepsis-associated encephalopathy: a comprehensive systematic review and meta-analysis.Frontiers in neurology · 2025Pooled it
- Ulinastatin Treatment Associated with Lower Sepsis-Associated Encephalopathy Risk in Sepsis Patients: A Multicenter Observational Study.Shock (Augusta, Ga.) · 2026Observational
- Endothelial-specific Ezh2 deficiency exacerbates blood-brain barrier dysfunction and neuroinflammation in sepsis-associated encephalopathy.Journal of neuroinflammation · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
We investigated the relationship between prefrontal functional connectivity of oxyhemoglobin and outcomes in sepsis-associated encephalopathy (SAE). Additionally, we developed a prognostic method for patients with SAE. A total of 40 consecutive patients with SAE were prospectively included. Cerebral oxyhemoglobin data were obtained using functional near-infrared spectroscopy. Functional connectivity such as density was evaluated as the strength of the temporal correlation between channels based on Pearson's correlation coefficient of oxyhemoglobin. We obtained clinical information and evaluated severity scores using Acute Physiology and Chronic Health Evaluation (APACHE) III. Outcomes were evaluated using the modified Rankin Scale (mRS) at discharge. Patients were categorized into two groups: good outcome (mRS 0-3), and poor outcome (mRS 4-6). Among the patients with SAE, 17 (42.5%) had good outcomes. Regarding connectivity analysis, density values were significantly higher in good outcome groups at all threshold values. The developed predictive method of good outcomes using the density value at a threshold of 0.6 and the APACHE III score showed very good predictive power (area under the curve 0.951 [95% confidence interval 0.893-1.00]). This method had better discrimination powers for predicting outcome than density had at 0.6 (0.716 [0.557-0.876]; P = 0.04) or the APACHE III score had alone (0.857 [0.735-0.979]; P = 0.09). A higher functional connectivity value of oxyhemoglobin in the prefrontal connectivity analysis was associated with good outcomes in SAE. Functional connectivity analysis of the prefrontal cortex and sepsis severity may help predict the prognosis in SAE patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.